Support First Things by turning your adblocker off or by making a  donation. Thanks!

The Man of the Crowd at the Inauguration

Edgar Allan Poe’s bicentennial birthday passed unremarked by this publication January 19. For the most part I considered Poe useful mainly as a horrible example of how not to write. Every so often, though, something characteristic took shape in his odd imagination. One of his lesser-known . . . . Continue Reading »

Thomas Disch in Boston Review

As some readers will remember, our October 2008 issue contained a posthumous poem by Thomas Disch (along with a poem in memory of Disch by David Mason). If you want to learn more about the work of this brilliant novelist, essayist, and poet, read this piece by science fiction writer John Crowley, . . . . Continue Reading »

Canned Music at the Inaugural

So it turns out that that Itzhak Perlman, Gabriela Montero, and Yo-Yo Ma were faking it at their Inaugural performance , playing along with a pre-recorded soundtrack instead of toughing it out in the cold. Yo-Yo Ma as the new Milli Vanilli. In the future, everyone will be lip-sync’ed for 15 . . . . Continue Reading »

Geron ESCR Drug Approved for Human Trial

Well after years of saying it was coming, finally Geron got permission to attempt a human trial of its ESC-derived drug for acute spinal cord injury. (This is not a direct infusion of stem cells, but of a type of adult neural stem cell created by differentiating the ES cells.) This is not an . . . . Continue Reading »

After the March

I got back late last night from the March for Life in Washington. It was my first time at the march, and I’m extremely glad I went. The crowds were huge and relatively upbeat, considering the new battles the movement is facing. I can think of no other protest that gathers such a diverse crowd . . . . Continue Reading »

What They Don’t Tell You about Stem Cells

The news is being triumphantly proclaimed, under banners of scientific liberation and medical messianism: The FDA yesterday approved the first trial of embryonic stem-cell treatment. It is a “research milestone,” says the New York Times , a “watershed moment,” adds the Wall . . . . Continue Reading »

Tags

Loading...

Filter First Thoughts Posts